Výsledky vyhledávání - "Giorgiana Hatu"

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy

Autor: Majid Amiri, François Bailly, Marie-Claude Gagnieu, Patrick Miailhes, Mathilde Leclercq, Marianne Maynard, Victor Virlogeux, Fanny Lebossé, Fabien Zoulim, Pierre Pradat, Giorgiana Hatu

Publikováno v: Hepatitis Monthly

Background: Anemia is more frequent in patients receiving telaprevir with PEGylated interferon/ribavirin (PEG-IFN/RBV) than in those receiving PEG-IFN/RBV alone. Objectives: The objective was to measure the impact of telaprevir on RBV bioavailability

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58f9ec872777061b787306dcbcb97f69
https://doi.org/10.5812/hepatmon.28879

Zobrazit plný text záznamu

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

Autor: Marie-Claude Gagnieu, Patrick Miailhes, Jean-Michel Livrozet, Fabien Zoulim, François Parant, François Bailly, Marianne Maynard, Pierre Chiarello, Giorgiana Hatu, Pierre Pradat, Emmanuel Pourcelot

Publikováno v: BMC Infectious Diseases
BMC Infectious Diseases, 2014, 14 (1), pp.150. ⟨10.1186/1471-2334-14-150⟩
BMC Infectious Diseases, BioMed Central, 2014, 14 (1), pp.150. ⟨10.1186/1471-2334-14-150⟩

International audience; BACKGROUND: In HIV infected patients, the impact of ribavirin (RBV) pharmacology on sustained virologic response (SVR) to hepatitis C virus (HCV) treatment has not been fully investigated. The objective of this study was to co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b1de6531a51ebfc65740ed4d9b64edb
http://europepmc.org/articles/PMC3994577

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání